60.39

0.54% -0.33

Pre-market: 60.39

Globus Medical Inc (GMED)

Overview News Price History Option Chain Financials Discussions Forecast

Globus Medical Inc stock is traded at $60.39, with a volume of 1.50M. It is down -0.54% in the last 24 hours and up +5.45% over the past month. Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Previous Close:

$60.72

Open:

$60.85

24h Volume:

1.50M

Relative Volume:

1.13

Market Cap:

$8.16B

Revenue:

$2.51B

Net Income/Loss:

$185.56M

P/E Ratio:

45.07

EPS:

1.34

Net Cash Flow:

$517.59M

1W Performance:

-3.05%

1M Performance:

+5.45%

6M Performance:

-15.86%

1Y Performance:

-17.88%

1-Day Range:

$60.11

$61.60

1-Week Range:

$60.11

$64.32

52-Week Range:

$51.79

$94.93

Globus Medical Inc Stock (GMED) Company Profile

Name

Globus Medical Inc

Sector

Healthcare (1135)

Industry

Medical Devices (144)

Phone

610-930-1800

Address

2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA

Employee

5,300

Twitter

@GlobusMedical

Next Earnings Date

2024-11-05

Latest SEC Filings

GMED's Discussions on Twitter

Compare GMED with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
GMED Globus Medical Inc	60.39	8.20B	2.51B	185.56M	517.59M	1.34
ABT Abbott Laboratories	123.62	216.79B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	100.72	149.02B	19.35B	2.78B	3.49B	1.8696
SYK Stryker Corp	356.24	141.06B	24.38B	2.94B	4.02B	7.6145
MDT Medtronic Plc	90.70	116.68B	34.20B	4.69B	5.30B	3.6218
EW Edwards Lifesciences Corp	82.45	49.01B	5.88B	1.34B	577.90M	2.3455

Globus Medical Inc Stock (GMED) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-28-25	Resumed	Stifel	Hold
May-27-25	Downgrade	BTIG Research	Buy → Neutral
Jan-10-25	Upgrade	BofA Securities	Underperform → Neutral
Dec-02-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-07-24	Upgrade	Wells Fargo	Equal Weight → Overweight
May-20-24	Upgrade	Piper Sandler	Neutral → Overweight
Mar-18-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	ROTH MKM	Buy
Sep-19-23	Upgrade	Stifel	Hold → Buy
Mar-30-23	Upgrade	Canaccord Genuity	Hold → Buy
Feb-13-23	Downgrade	BofA Securities	Buy → Underperform
Feb-10-23	Downgrade	BTIG Research	Buy → Neutral
Feb-10-23	Downgrade	Loop Capital	Buy → Hold
Feb-10-23	Downgrade	Needham	Buy → Hold
Feb-10-23	Downgrade	Truist	Buy → Hold
Feb-10-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-18-22	Initiated	Barclays	Overweight
Oct-12-22	Initiated	Jefferies	Buy
Apr-13-22	Resumed	Truist	Buy
Mar-28-22	Initiated	Wells Fargo	Overweight
Jan-04-22	Upgrade	Piper Sandler	Neutral → Overweight
Dec-13-21	Upgrade	BofA Securities	Underperform → Buy
Dec-10-21	Initiated	RBC Capital Mkts	Outperform
Oct-29-21	Initiated	Loop Capital	Buy
Feb-18-21	Resumed	Needham	Buy
Dec-08-20	Initiated	Citigroup	Buy
Oct-20-20	Initiated	Stifel	Hold
Aug-06-20	Reiterated	Needham	Buy
Aug-06-20	Upgrade	Northland Capital	Market Perform → Outperform
Jul-21-20	Initiated	Northland Capital	Market Perform
Jul-06-20	Downgrade	Piper Sandler	Overweight → Neutral
May-08-20	Reiterated	Needham	Buy
Mar-18-20	Upgrade	BTIG Research	Neutral → Buy
Jan-08-20	Initiated	SunTrust	Buy
Dec-12-19	Upgrade	Wells Fargo	Market Perform → Outperform
Aug-02-19	Reiterated	Needham	Buy
May-24-19	Downgrade	Wells Fargo	Outperform → Market Perform
May-03-19	Reiterated	Needham	Buy
Feb-28-19	Upgrade	UBS	Neutral → Buy
Jan-02-19	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-02-18	Reiterated	Needham	Buy
Jun-27-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jun-01-18	Initiated	Cantor Fitzgerald	Overweight
May-03-18	Reiterated	Needham	Buy
Apr-04-18	Upgrade	Needham	Hold → Buy

View All

Globus Medical Inc Stock (GMED) Latest News

06:26 AM

Cambiar Investors LLC Buys 139,548 Shares of Globus Medical, Inc. $GMED - MarketBeat

06:26 AM

04:27 AM

Strs Ohio Sells 48,464 Shares of Globus Medical, Inc. $GMED - MarketBeat

04:27 AM

01:38 AM

Is Globus Medical Inc. stock positioned for digital transformationTrade Signal Summary & Free Accurate Trade Setup Notifications - newser.com

01:38 AM

01:19 AM

Tools to monitor Globus Medical Inc. recovery probabilityMarket Movement Recap & Risk Controlled Swing Trade Alerts - newser.com

01:19 AM

12:37 PM

Evaluating Globus Medical Inc. with trendline analysisTrade Entry Report & Long-Term Investment Growth Plans - newser.com

12:37 PM

Nov 02, 2025

Can Globus Medical Inc. recover in the next quarterMarket Activity Report & Risk Controlled Daily Trade Plans - newser.com

Nov 02, 2025

Is Globus Medical Inc. still worth holding after the dipWeekly Stock Recap & Real-Time Volume Analysis - newser.com

Nov 02, 2025

Geneva Capital Management LLC Buys 249,141 Shares of Globus Medical, Inc. $GMED - MarketBeat

Nov 02, 2025

How buyback programs support Globus Medical Inc. Class stockWatch List & Real-Time Market Sentiment Reports - newser.com

Nov 02, 2025

How Globus Medical Inc. Class stock reacts to weak economy2025 Top Decliners & Safe Capital Growth Tips - newser.com

Nov 02, 2025

Nov 01, 2025

Will Globus Medical Inc. Class stock benefit from sector leadershipJuly 2025 Chart Watch & High Accuracy Investment Entry Signals - newser.com

Nov 01, 2025

Can Globus Medical Inc. stock deliver sustainable ROETrade Risk Assessment & Proven Capital Preservation Methods - newser.com

Nov 01, 2025